BioAtla (BCAB) Current Leases (2021 - 2026)
BioAtla (BCAB) posted quarterly Current Leases of $1.6 million for Q1 2026, up 181.41% year-over-year from $554000.0 in Q1 2025, and up 9.25% quarter-over-quarter from $1.4 million in Q4 2025.
BioAtla (BCAB) Current Leases (2021 - 2026) Analysis & Trends
BioAtla's Current Leases history runs 6 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Current Leases rose 181.41% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 181.41% YoY), while the FY2025 annual figure was $1.4 million, up 70.69% from the prior year.
- Current Leases for Q1 2026 stood at $1.6 million, up from $1.4 million in the prior quarter.
- The five-year high for Current Leases was $1.7 million in Q2 2024, with the low at $554000.0 in Q1 2025.
- The 5-year median for Current Leases is $1.5 million (2022), against an average of $1.4 million.
- The sharpest annual moves came in 2025 and 2026: Current Leases slumped 63.29% in 2025, then jumped 181.41% in 2026.
- BioAtla's Current Leases stood at $1.5 million in 2022, then climbed by 6.77% to $1.6 million in 2023, then plunged by 48.52% to $836000.0 in 2024, then surged by 70.69% to $1.4 million in 2025, then advanced by 9.25% to $1.6 million in 2026.
- Business Quant data shows BCAB's Current Leases at $1.6 million in Q1 2026, $1.4 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | - |
| 10 | BioAtla | 5.41 Mn | 5.41 Mn | - | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57 Mn |
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 1.43 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 805,000.00 |
| Mar 31, 2025 | 554,000.00 |
| Dec 31, 2024 | 836,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 1.48 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 1.39 Mn |